C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2002
08/01/2002	WO2002058637A2 Compositions and methods for diagnosis of neuropsychiatric disorders
08/01/2002	WO2002058628A2 Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands
08/01/2002	WO2002058627A2 A cystic fibrosis transmembrane-conductance regulator (cftr)-membrane translocation sequence fusion protein (cftr-mts) as a therapeutic agent
08/01/2002	WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/01/2002	WO2002058589A2 Agents and methods for promoting bone growth
08/01/2002	WO2002058546A2 Methods for screening for substances which inhibit fp prostanoid receptor
08/01/2002	WO2002058534A2 Compositions and methods for the therapy and diagnosis of colon cancer
08/01/2002	WO2002058450A2 Regulation of cell growth by muc1
08/01/2002	WO2002042480A3 Modified vaccinia ankara virus variant
08/01/2002	WO2002036832A3 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
08/01/2002	WO2002036761A9 Compositions and methods for the diagnosis of cancer
08/01/2002	WO2002034878A3 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis
08/01/2002	WO2002033107A3 Plant cell death system
08/01/2002	WO2002033106A3 Plant cell death system
08/01/2002	WO2002032924A3 Haplotypes of the chrm5 gene
08/01/2002	WO2002032923A3 Improved formulations using heat shock/stress protein-peptide complexes
08/01/2002	WO2002022681A3 Neuronally expressed protein and use thereof
08/01/2002	WO2002020719A3 MAMMALIAN NON-ERYTHROID Rh TYPE C GENES AND GLYCOPROTEINS
08/01/2002	WO2002020596A3 Maurotoxin, pi1 and hstx1 derivatives
08/01/2002	WO2002019986A9 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions
08/01/2002	WO2002017963A3 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
08/01/2002	WO2002014359A3 Human serpin zserp15
08/01/2002	WO2002010338A3 Expression of gage/page-like protein in benign prostatic hyperplasia
08/01/2002	WO2002010336A3 Mutacin i biosynthesis genes and proteins
08/01/2002	WO2002009649A8 Cell internalized peptide-drug conjugates
08/01/2002	WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002	WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
08/01/2002	WO2002004497A3 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2002000928A3 Diagnosis of diseases associated with the immune system by determining cytosine methylation
08/01/2002	WO2002000903A3 Esr1 - a plant gene that can promote plant regeneration and transformation
08/01/2002	WO2002000718A3 A human calcium channel protein and uses thereof
08/01/2002	WO2002000684A3 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
08/01/2002	WO2001098352A3 Thrombomodulin analogs for pharmaceutical use
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001090163A3 Use of the gabab receptor in assays to identify gamma hydroxybutyrate agonists, antagonists, and allosteric modulators of agonists
08/01/2002	WO2001087925A3 Methods for refolding proteins containing free cysteine residues
08/01/2002	WO2001083736A3 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
08/01/2002	WO2001083554A3 Anti-inflammatory compounds and uses thereof
08/01/2002	WO2001083527A3 Glucagon antagonists
08/01/2002	WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
08/01/2002	WO2001077157A3 Full-length gb virus c (hepatitis g virus) rna transcripts are infectious in primary cd4 positive t cells and methods of treating hiv
08/01/2002	WO2001075114A3 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
08/01/2002	WO2001075113A3 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
08/01/2002	WO2001075110A3 Mucin-1 specific binding members and methods of use thereof
08/01/2002	WO2001074863A3 Chlamydia antigens and corresponding dna fragments and uses thereof
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
08/01/2002	WO2001070955A3 Identification of essential genes in prokaryotes
08/01/2002	WO2001062912A3 Method of modulating glycosylation pathways
08/01/2002	WO2001045492A3 Protein kinase stress-related proteins and methods of use in plants
08/01/2002	WO2001041815A3 Metastasis genes and uses thereof
08/01/2002	WO2001034808A9 Method of large-scale production and method of testing of the biological activity of a substance from soybean
08/01/2002	WO2001034635A9 Methods and compositions for peptide synthesis
08/01/2002	WO2001032688A9 Renilla reniformis green fluorescent protein
08/01/2002	WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use
08/01/2002	WO2001026678A9 Short segments of dap-kinase
08/01/2002	WO2001026675A9 FcηRIA
08/01/2002	WO2001000672A9 Secreted proteins and uses thereof
08/01/2002	WO2001000667A9 Anti-thrombin peptide from anopheles albimanus salivary gland
08/01/2002	WO2000077040A9 Human intracellular signaling molecules
08/01/2002	US20020104130 Isolation and characterization of heat shock protein
08/01/2002	US20020104127 Genetically engineered plant cells for use in the generation of heterlogous proteins
08/01/2002	US20020104123 Viral amplification of recombinant messenger RNA in transgenic plants
08/01/2002	US20020104122 Generating disease resistant plants; obtain plants, transform with expression vector, propagate and monitor plants resistance to disease
08/01/2002	US20020104119 Transcription regulatory sequences derived from Chlamydomonas reinhardtii
08/01/2002	US20020104117 Nucleotide sequence coding for use as tools in the generation of disease and herbicide resistant plants
08/01/2002	US20020104116 Generating disease resistant plants; obtain plant, transform with viral nucleotide sequences, recover transform plant, monitor for disease resistance
08/01/2002	US20020104114 Mammalian animal model for use in the evaluation and treatment of brain tumors
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020104112 Ikaros regulatory elements and uses thereof
08/01/2002	US20020104110 Immunologically privileged cells and uses thereof
08/01/2002	US20020104109 Transgenic animals
08/01/2002	US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors
08/01/2002	US20020104107 Animal model for use in developing treatment for nicotine addiction and epilepsey
08/01/2002	US20020104106 Fly model for evaluating tumor propagation
08/01/2002	US20020104105 Polypeptide complex; for use in the treatment of diabetes and nervous system disorders
08/01/2002	US20020104104 Method for identifying alzheimer's disease therapeutics using transgenic animal models
08/01/2002	US20020103363 Promoter derived from phytosulfokine precursor gene
08/01/2002	US20020103362 Polypeptide compositions toxic to anthonomus insects, and methods of use
08/01/2002	US20020103360 Novel protein related to melanoma-inhibiting protein and uses thereof
08/01/2002	US20020103359 Nucleotide sequences coding polypeptide for use in treatment and diagnosis of psychologicaland eating disorders
08/01/2002	US20020103358 Nucleotide sequences coding preferential polypeptide for use in tumor therapy
08/01/2002	US20020103357 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids, medicines and human nutrients
08/01/2002	US20020103356 Sequences which code for the sigE gene
08/01/2002	US20020103355 Purified plant expansin proteins and DNA encoding same
08/01/2002	US20020103353 Sequences characteristic of hypoxia-regulated gene transcription
08/01/2002	US20020103351 32146 and 57259, novel human transporters and uses therefor
08/01/2002	US20020103346 Reptile venom polypeptide for use in reduction of complement activity
08/01/2002	US20020103344 Glycoprotein mutants of retrovirus envelopes and their biological applications
08/01/2002	US20020103342 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, reproductive, immunological, and tumor disorders
08/01/2002	US20020103341 Annexin derivatives with endogenous chelation sites
08/01/2002	US20020103339 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and immune disorders
08/01/2002	US20020103338 Staphylococcus aureus polynucleotides and polypeptides
08/01/2002	US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002	US20020103336 Cloning of chicken anemia dna
08/01/2002	US20020103335 Peptide derivatives
08/01/2002	US20020103334 Aprotinin variants having a net charge of +3 to -3 at pH 7 and with the amino acids Arg15 or Arg15-Ala17 in the binding region; serine protease inhibitor
08/01/2002	US20020103155 Vectors for the expression of FGF-5 in human cells and uses thereof
08/01/2002	US20020103154 Identifying genes, e.g. Saccharomyces cerevisiae, essential for germination and proliferation and using the identified genes or their encoded proteins as targets for highly specific fungicides, etc.; antifungal agents,

1 ... 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 ... 2916